Navigation Links
Human Papillomavirus (HPV) DNA Probe, High Risk, Cervix

ProductsHuman Papillomavirus (HPV) DNA Probe, High Risk, Cervix
Company ARUP Laboratories
Item Human Papillomavirus (HPV) DNA Probe, High Risk, Cervix
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. EPO EIA Human Cytokines 021-SDX021 Erythropoietin Anemia
2. Human Growth Hormone EIA Endocrine Function 025-BC-1033
3. Human Ferritin
4. Human Chorionic Gonadotropin (HCG) ELISA Kit
5. Human PSA ELISA Kit
6. Human Myoglobin Enzyme Immunoassay
7. Human Cardiac-Specific Troponin-I Enzyme Immunoassay (cTnI ELISA)
8. Antigen-Antibody Pen For Human Primary antibodies
9. Lyphochek Unassayed Chemistry Control (Human)
10. Liquichek Unassayed Chemistry Control (Human)
11. Human Growth Hormone (hGH)
Other Medicine News:Health News:Nurses Report Quality Health Benefits Key to Choosing an Employer 2Health News:Pilot Program Successfully Addresses Mental Health Issues in Pennsylvania's Children 2Health News:First Patients Treated in Italy With the Percutaneous MitraClip(R) System 2Health News:First Patients Treated in Italy With the Percutaneous MitraClip(R) System 3Health News:Become Mariah Carey's Personal Fashion Designer! 2Health News:Become Mariah Carey's Personal Fashion Designer! 3Health News:Become Mariah Carey's Personal Fashion Designer! 4Health News: Booz & Company Study Finds Top Corporate Spenders on R&D Boosted Investments to Nearly Half a Trillion Dollars in 2007 2Health News: Booz & Company Study Finds Top Corporate Spenders on R&D Boosted Investments to Nearly Half a Trillion Dollars in 2007 3Health News: Booz & Company Study Finds Top Corporate Spenders on R&D Boosted Investments to Nearly Half a Trillion Dollars in 2007 4Health News: Booz & Company Study Finds Top Corporate Spenders on R&D Boosted Investments to Nearly Half a Trillion Dollars in 2007 5Health News: Booz & Company Study Finds Top Corporate Spenders on R&D Boosted Investments to Nearly Half a Trillion Dollars in 2007 6Health News: Booz & Company Study Finds Top Corporate Spenders on R&D Boosted Investments to Nearly Half a Trillion Dollars in 2007 7
Breaking Medicine Technology:Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 2Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 3Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 4Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 5Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2CryoLife Provides Initial 2010 Financial Guidance 6633 1CryoLife Provides Initial 2010 Financial Guidance 6633 2CryoLife Provides Initial 2010 Financial Guidance 6633 3CryoLife Provides Initial 2010 Financial Guidance 6633 4CryoLife Provides Initial 2010 Financial Guidance 6633 5MedQuist Integrates Search Engine from Primordial with SpeechQ 28TM 29 for Radiology 6630 1MedQuist Integrates Search Engine from Primordial with SpeechQ 28TM 29 for Radiology 6630 2Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 6627 1Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 6627 2